AWC Annual Report blank template 2015

advertisement
ANNUAL REPORT
FLINDERS UNIVERSITY and SOUTHERN ADELAIDE LOCAL HEALTH NETWORK
Animal Welfare Committee
COMBINED ANNUAL STATISTICS and PROGRESS REPORT
For year ending 31 December 2015
[Pursuant to the Australian Code for the Care and Use of Animals for Scientific Purposes, 8th edition, 2013]
Instructions
Use this form for Continuing projects
Please email the signed and completed report to animal.welfare@flinders.edu.au
1. PROJECT INFORMATION:
PROJECT NUMBER
PROJECT TITLE
APPROVAL DATE
ORIGINAL EXPIRY DATE
COMMENCEMENT DATE
CURRENT EXPIRY DATE
MODIFICATIONS SINCE APPROVAL (Including PENDING modifications) (Duplicate rows as required)
Type of Modification Approved
Modification
Approval Date
(a) Extension of time
(b) Modified or additional experimental steps;
additional / change to animals / species
(c) Change of personnel
2. CHIEF INVESTIGATOR:
NAME (Title, First Name, Family Name)
SCHOOL/DEPARTMENT/ORGANISATION
SUPERVISOR (If applicable)
DAY TIME PHONE NO.
FAX NO.
EMAIL ADDRESS
3. STATUS:
If “In progress”, please answer EVERY question even if the answer is “No further changes have been made”.
3.1 Status of Project: Is the project:
Not Commenced
Suspended, temporarily
3.2 If not commenced or suspended, please state reason.
For projects Not Commenced, please go to section 6, Certification and Signatures.
In Progress
ANNUAL REPORT
4. STATISTICS: ANIMALS USED
4.1 PURPOSE OF PROJECT
Understanding biology
Maintenance and improvement of human or animal health or welfare
Improvement of animal management or production
Achievement of educational objectives
Environmental study
Please tick ONE only
4.2 REDUCTION, REFINEMENT, REPLACEMENT
Please outline below any initiatives you have undertaken to reduce the number of animals used, improve the
manner in which they are housed or used or which have enabled you to replace animals with alternatives.
NB: Please replicate the following table if more than one Category of Animal is used in this project and/or add
additional rows to the Animal Type/s section, as necessary.
4.3 ANIMAL CATEGORY Refer to attached Animal Category/Type classification table
Aquatic
Bird
Domestic
Exotic Feral
Laboratory Mammals
Native Mammals
Primate
Reptile
Stock
Zoo
TOTAL
4.4 ANIMAL TYPE/S
GM
ANIMAL IMPACT /
NUMBER
Please select from type listed
Yes
PROCEDURE TYPE
APPROVED
for the category you have
Please select from attached table; if
or
(incl.
specified above: see
more
than
one
procedure,
record
No
attached Animal
Category/Type classification
table
only the most invasive
modifications)
Please tick ONE only
TOTAL
NUMBER
ACTUALLY
USED
TO DATE
TOTAL
NUMBER
USED
BETWEEN
1/1/2015 &
31/12/2015
5. PROGRESS:
5.1 For projects in progress or suspended, please briefly outline progress to date. (Progress reports to funding
bodies may be attached.)
5.2 Have there been any problems that have interfered with progress of the project?
Yes
Briefly explain the problems:
No
ANNUAL REPORT
5.3 Have any unexpected adverse events OR animal welfare issues arisen that are inconsistent with those
anticipated in the original proposal or an approved modification?
Yes
No
If yes, please briefly explain:
5.4 How many Unexpected Adverse Event Reports have been submitted?
5.4.1
Number of reports submitted between 01/01/2015 & 31/12/2015:
5.4.2
Number of reports submitted since Approval:
5.4.3
Total mortality rate experienced since Approval:
5.5 Have there been any modifications to the project that have not been referred to the AWC for approval?
Yes
No
If yes, please briefly explain:
5.6 Do you envisage any changes to the protocol as approved (eg in personnel, animal numbers…)?
Yes
No
Yes
No
If so, what are they?
5.7 To date, is the project meeting the aims stated in the original proposal?
If No, please outline why they are not being met.
6. CERTIFICATION & SIGNATURES
I, the Chief Investigator for this project, certify that, except where indicated above, this research
project has been conducted in accordance with the approved protocol.
Name:
Signature:
Date:
ANNUAL REPORT
Attachment: Classifications of Animal Type by Category and Definitions of Animal Impact / Procedure
Please delete this page from completed report form before submitting.
Higher category
Amphibians
Lower category
Amphibians
Aquatic Animals Cephalopods, Crustaceans, Fish, other aquatic animals
Birds
Exotic Captive, Exotic Wild, Native Captive, Native Wild, Poultry, other
birds
Domestic
Mammals
Cats, Dogs, Cattle, Deer, Goats, Horses, Pigs, Sheep, other domestic
mammals
Exotic Feral
Mammals
Camels, Cats, Cattle, Goats, Hares, Horses, Mice, Pigs, Rabbits, Rats,
Wild Dogs and Foxes, other exotic feral mammals
Laboratory
Mammals
Ferrets, Guinea Pigs, Hamsters, Mice, Rabbits, Rats, other laboratory
mammals
Dasyurids, Koalas, Macropods, Native Rats and Mice, Possums and
Native Mammals Gliders, Wombats, Monotremes, Seals, Whales and Dolphins, other
native mammals
Primates
Baboons, Macaques, Marmosets, other primates
Reptiles
Lizards, Snakes, Turtles and Tortoises, other reptiles
Exotic Zoo
Animals
Exotic Zoo Animals
Animal Impact (Procedure)
Only one type of procedure per entry should be recorded. The basis for the decision should be
based on the following National Health and Medical Research Council (NHMRC) criteria:
Observation with Minor Interference – Breeding, Reproductive, Genetic or
Behavioural Study; Feeding trial
Animal Unconscious No Recovery – Animals killed painlessly for biochemical
analysis, in vitro cell tissue or organ studies; Animal are fully anaesthetised for
duration and killed in conclusion without recovery from anaesthesia
Minor Conscious Procedure – Injections, blood sampling, minor dietary or
environmental manipulation
Minor Operative Procedure with Recovery – Biopsies, cannulations
Surgery with Recovery – Orthopaedic, abdominal or thoracic
Minor Physiological Challenge – Minor infections, minor or moderate genetic
modification, early oncogenesis; Arthritis studies with pain alleviation, controlled
metabolic disease; Residue testing; polyclonal antibody production
Physiological Challenge – Major infection, major genetic modification,
oncogenesis without pain relief; Arthritis studies with no pain alleviation,
uncontrolled metabolic disease; Isolation or environmental deprivation for extended
periods; Monoclonal antibody raising in mice.
Death as an Endpoint, Lethality testing, Vaccination trials.
Download